Abstract
Multi-drug resistant bacteria are appearing at an alarming rate and impose significant burdens on healthcare systems worldwide. Cationic peptides have shown great promise as broad spectrum antimicrobial agents with a demonstrated ability to kill resistant bacteria, however, issues such as protease susceptibility and toxicity issues have delayed their clinical development. This review summarizes recent progress in the advancement of cationic antimicrobial peptides for the treatment of bacterial infections. The major focus of the discussion relates to recent advances in the areas of screening and in silico modeling. A selection of novel strategies that diverge from classical linear α-peptide antimicrobials is also discussed. A diverse array of candidate structures will be key to the ultimate development of a stable platform for clinical development. The ability to accurately predict peptide activity in silico and in a high-throughput manner should benefit all classes of cationic antimicrobial peptides and provide a larger set of candidate structures for clinical evaluation.
Keywords: Antimicrobial, Cationic, Peptide/kwd, >, QSAR, screening, in silico, Cationic Antimi-crobial Peptides, Multi-drug resistant, broad spectrum, protease susceptibility, Peptide, Gram negative bacteria, Pseudomonas aeruginosa, Gram-positive, innate immunity, structure activity relationships, host defense pep-tides, glycosaminoglycans, red blood cell hemolysis, lipopolysaccharides, teichoic, zwitterionic lipids, threshold level, nucleic acid synthesis, second-generation peptides, SPOT synthesis technique, luxCDABE-expressing Pseudo-monas aeuruginosa, Bac2a- and Bac2a-, EC50 values, artificial neural network, methicillin-resistant S. aureus, ana-phylatoxin peptide C3a., benchmark peptide LL37, lipids phosphatidylcholine, phosphatidylglycerol, dipiccolinic acid, linear -peptide antimicrobials, neurokinin derived peptides GKH17 and HKH17, PEGylation of peptides, Polymyxins, cationic cyclic lipopeptides, hydrophobic antibiotics, Peptide Mimics
Current Topics in Medicinal Chemistry
Title: Strategies for the Discovery and Advancement of Novel Cationic Antimicrobial Peptides
Volume: 10 Issue: 18
Author(s): E. B. Hadley and R. E.W. Hancock
Affiliation:
Keywords: Antimicrobial, Cationic, Peptide/kwd, >, QSAR, screening, in silico, Cationic Antimi-crobial Peptides, Multi-drug resistant, broad spectrum, protease susceptibility, Peptide, Gram negative bacteria, Pseudomonas aeruginosa, Gram-positive, innate immunity, structure activity relationships, host defense pep-tides, glycosaminoglycans, red blood cell hemolysis, lipopolysaccharides, teichoic, zwitterionic lipids, threshold level, nucleic acid synthesis, second-generation peptides, SPOT synthesis technique, luxCDABE-expressing Pseudo-monas aeuruginosa, Bac2a- and Bac2a-, EC50 values, artificial neural network, methicillin-resistant S. aureus, ana-phylatoxin peptide C3a., benchmark peptide LL37, lipids phosphatidylcholine, phosphatidylglycerol, dipiccolinic acid, linear -peptide antimicrobials, neurokinin derived peptides GKH17 and HKH17, PEGylation of peptides, Polymyxins, cationic cyclic lipopeptides, hydrophobic antibiotics, Peptide Mimics
Abstract: Multi-drug resistant bacteria are appearing at an alarming rate and impose significant burdens on healthcare systems worldwide. Cationic peptides have shown great promise as broad spectrum antimicrobial agents with a demonstrated ability to kill resistant bacteria, however, issues such as protease susceptibility and toxicity issues have delayed their clinical development. This review summarizes recent progress in the advancement of cationic antimicrobial peptides for the treatment of bacterial infections. The major focus of the discussion relates to recent advances in the areas of screening and in silico modeling. A selection of novel strategies that diverge from classical linear α-peptide antimicrobials is also discussed. A diverse array of candidate structures will be key to the ultimate development of a stable platform for clinical development. The ability to accurately predict peptide activity in silico and in a high-throughput manner should benefit all classes of cationic antimicrobial peptides and provide a larger set of candidate structures for clinical evaluation.
Export Options
About this article
Cite this article as:
B. Hadley E. and E.W. Hancock R., Strategies for the Discovery and Advancement of Novel Cationic Antimicrobial Peptides, Current Topics in Medicinal Chemistry 2010; 10 (18) . https://dx.doi.org/10.2174/156802610793176648
DOI https://dx.doi.org/10.2174/156802610793176648 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
1,3,4-Thiadiazole Based Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Oxidative Stress, Endothelial Dysfunction and Atherosclerosis
Current Pharmaceutical Design Update on the Therapies of Severe Lupus Nephritis
Current Rheumatology Reviews Modulation of GABAA Receptors by Natural Products and the Development of Novel Synthetic Ligands for the Benzodiazepine Binding Site
Current Drug Targets One-pot Synthesis of Pyrano[2,3-c]pyrazole Derivatives <i>via</i> Multicomponent Reactions (MCRs) and their Applications in Medicinal Chemistry
Mini-Reviews in Organic Chemistry Nuclear Receptors as Potential Targets for Modulating Reverse Cholesterol Transport
Current Topics in Medicinal Chemistry Drug Re-purposing from SARS-CoV Led the Identification of Potential Candidate Drug Target and Alternate Drug Molecules Against SARSCoV- 2
Letters in Drug Design & Discovery Coumarins and Quinolones as Effective Multiple Targeted Agents Versus Covid-19: An <i>In Silico</i> Study
Medicinal Chemistry GABA System as a Target for New Drugs
Current Medicinal Chemistry Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy Antiviral Drug Discovery and Development for Mayaro Fever – What do we have so far?
Mini-Reviews in Medicinal Chemistry Gastrointestinal, Liver, Pancreas, Oral and Psychological Long-term Symptoms of COVID-19 After Recovery: A Review
Mini-Reviews in Medicinal Chemistry Molnupiravir in COVID-19: A Scoping Review
Current Drug Research Reviews Glucocorticoid Receptor Antagonists
Current Topics in Medicinal Chemistry Photochemical Advanced Oxidation Processes for Water and Wastewater Treatment
Recent Patents on Engineering The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
Current Medicinal Chemistry AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders
Current Topics in Medicinal Chemistry Recent Advances in the Development of Small-molecule CCR5 Inhibitors for HIV
Mini-Reviews in Medicinal Chemistry Advances in the Oxidation of Biginelli Compounds
Current Organic Chemistry Recent Advances in the Development of Casein Kinase 1 Inhibitors
Current Medicinal Chemistry